These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8175673)

  • 1. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells.
    Gao WY; Agbaria R; Driscoll JS; Mitsuya H
    J Biol Chem; 1994 Apr; 269(17):12633-8. PubMed ID: 8175673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
    J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells.
    Shirasaka T; Chokekijchai S; Yamada A; Gosselin G; Imbach JL; Mitsuya H
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2555-9. PubMed ID: 8585744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
    Gao WY; Shirasaka T; Johns DG; Broder S; Mitsuya H
    J Clin Invest; 1993 May; 91(5):2326-33. PubMed ID: 8387546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes/macrophages.
    Thumann-Schweitzer C; Gosselin G; Périgaud C; Benzaria S; Girardet JL; Lefebvre I; Imbach JL; Kirn A; Aubertin AM
    Res Virol; 1996; 147(2-3):155-63. PubMed ID: 8901435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamivudine (3TC) phosphorylation and drug interactions in vitro.
    Kewn S; Veal GJ; Hoggard PG; Barry MG; Back DJ
    Biochem Pharmacol; 1997 Sep; 54(5):589-95. PubMed ID: 9337075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
    Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
    Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
    Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anti-HIV 2'-beta-fluoro-2',3'-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production.
    Tsai CH; Doong SL; Johns DG; Driscoll JS; Cheng YC
    Biochem Pharmacol; 1994 Oct; 48(7):1477-81. PubMed ID: 7945448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Webb DS; Hao Z; Mitsuya H; Johns DG; Broder S
    J Exp Med; 1989 Mar; 169(3):933-51. PubMed ID: 2538549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddI.
    Chokekijchai S; Shirasaka T; Weinstein JN; Mitsuya H
    Antiviral Res; 1995 Sep; 28(1):25-38. PubMed ID: 8585758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 3'-deoxynucleoside 5'-triphosphate concentrations on chain termination by nucleoside analogs during human immunodeficiency virus type 1 reverse transcription of minus-strand strong-stop DNA.
    Arts EJ; Marois JP; Gu Z; Le Grice SF; Wainberg MA
    J Virol; 1996 Feb; 70(2):712-20. PubMed ID: 8551607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the SOS response in Escherichia coli by azidothymidine and dideoxynucleosides.
    Mamber SW; Brookshire KW; Forenza S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1237-43. PubMed ID: 2118327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells.
    Gröschel B; Kaufmann A; Höver G; Cinatl J; Doerr HW; Noordhuis P; Loves WJ; Peters GJ; Cinatl J
    Biochem Pharmacol; 2002 Jul; 64(2):239-46. PubMed ID: 12123744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs.
    Kierdaszuk B; Bohman C; Ullman B; Eriksson S
    Biochem Pharmacol; 1992 Jan; 43(2):197-206. PubMed ID: 1739408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells.
    Cui L; Locatelli L; Xie MY; Sommadossi JP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1228-34. PubMed ID: 9067308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages.
    Perno CF; Cooney DA; Gao WY; Hao Z; Johns DG; Foli A; Hartman NR; Caliò R; Broder S; Yarchoan R
    Blood; 1992 Aug; 80(4):995-1003. PubMed ID: 1379854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2',3'-dideoxynucleoside activities against replication of human immunodeficiency virus.
    Gao WY; Johns DG; Chokekuchai S; Mitsuya H
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8333-7. PubMed ID: 7667290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.
    Balzarini J
    Pharm World Sci; 1994 Apr; 16(2):113-26. PubMed ID: 8032337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapy of human immunodeficiency virus-related disease.
    Mitsuya H; Yarchoan R; Kageyama S; Broder S
    FASEB J; 1991 Jul; 5(10):2369-81. PubMed ID: 1712326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.